Preferred Label : Progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant
3;
Symbol : PEOA3;
CISMeF acronym : PEOA3;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Progressive external ophthalmoplegia, autosomal dominant 3;
Description : Progressive external ophthalmoplegia is characterized by multiple mitochondrial DNA
deletions in skeletal muscle. The most common clinical features include adult onset
of weakness of the external eye muscles and exercise intolerance. Patients with C10ORF2-linked
adPEO may have other clinical features including proximal muscle weakness, ataxia,
peripheral neuropathy, cardiomyopathy, cataracts, depression, and endocrine abnormalities
(summary by Fratter et al., 2010). For a general phenotypic description and a discussion
of genetic heterogeneity of autosomal dominant progressive external ophthalmoplegia,
see PEOA1 (157640). PEO caused by mutations in the POLG gene are associated with more
complicated phenotypes than those forms caused by mutations in the SLC25A4 (103220)
or C10ORF2 genes (Lamantea et al., 2002).;
Inheritance : Autosomal dominant;
Molecular basis : Caused by mutation in the TWINKLE mtDNA helicase gene (TWNK, 606075.0001);
Laboratory abnormalities : Increased serum lactate;
Prefixed ID : #609286;
Origin ID : 609286;
UMLS CUI : C1836439;
Automatic exact mappings (from CISMeF team)
Broader ORDO disease(s)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)